Gilead Sciences said on Saturday that it entered into a partnership with Denmark's LEO Pharma to develop programs to treat ...

Gilead Sciences (GILD) partners with LEO Pharma in a $1.7B agreement to develop anti-inflammatory drugs. Read more here.

Johnson & Johnson remains a Buy for its stability and consistent dividends, despite short-term price fluctuations and modest ...

Gilead Sciences, Inc. (GILD) and LEO Pharma entered strategic partnership to develop and commercialize LEO Pharma's small molecule ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Buy rating on Gilead Sciences (GILD – Research Report), with a price ...

Everseen today introduced Everseen Vision Agents, an AI innovation to optimize and transform business processes, creating the potential for unprecedented value for global retailers and other ...

Docking Drawer's Unwavering Dedication to Safety "At Docking Drawer, we're not just creating products; we're setting new standards for safety and functionality."When it comes to safety, no one in the ...

Gilead continues its divergence out of its original infectious disease beginnings and into cancer and now, more deeply than ...

As top pharma executives arrive in San Francisco, CA, to attend the J.P. Morgan Healthcare Conference next week, biotech dealmaking will be in focus as the annual event usually coincides with major ...

Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for ...

You can still view the video on YouTube. With 24 majors and 35 minors, Alfred University’s College of Liberal Arts & Sciences not only offers a wide selection of academic choices, but considerable ...

Ouro will leverage $120 million in funding to develop novel T cell engagers with potential to reset the immune system in patients with chronic immune-mediated ...